Proof of Principle for a Novel Class of Antihypertensives That Target the Oxidative Activation of PKG Iα (Protein Kinase G Iα)

Joseph R. Burgoyne(British Heart Foundation), Philip Eaton(William Harvey Research Institute)
Hypertension
July 18, 2017
Cited by 27


Related Papers